Related Experiment Video

Updated: Nov 24, 2025

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

1.2K

IgA nephropathy patients with partial crescent formation benefit from immunosuppressants: evidence from repeat renal

Mian-Na Luo1, Qingjun Pan1, Zhi-Qing Huang1

  • 1Key Laboratory of Prevention and Management of Chronic Kidney Disease of Zhanjiang City, Institute of Nephrology, Nephrology Department, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong 524001, China.

Discovery Medicine
|December 28, 2020
PubMed

Insights

Immunosuppressive therapy for IgA nephropathy (IgAN) with partial crescent formation shows short-term benefits. Treatment can reduce proteinuria, stabilize kidney function, and improve anemia in IgAN patients.

Area of Science:

  • Nephrology
  • Immunology
  • Pathology

Background:

  • Crescent formation is a key pathological feature in IgA nephropathy (IgAN).
  • Treatment guidelines recommend aggressive immunosuppression for IgAN with >50% crescent formation.
  • The necessity of immunosuppression for partial crescent formation in IgAN remains debated.

Purpose of the Study:

  • To evaluate the impact of immunosuppressive therapy on IgAN patients with partial crescent formation.
  • To assess changes in clinical and pathological markers following treatment.

Main Methods:

  • Retrospective analysis of IgAN patients with partial crescent formation undergoing repeat renal biopsy.
  • Comparison of clinical parameters and pathological indices between initial and follow-up biopsies.

Main Results:

  • Significant improvements observed in hemoglobin, albumin, and 24-hour urinary protein excretion post-treatment.
  • Decreased mesangial cell proliferation and a trend towards reduced crescent formation proportion noted.
  • No significant changes in blood pressure, creatinine, or estimated glomerular filtration rate; however, glomerulosclerosis and tubulointerstitial fibrosis increased.

Conclusions:

  • Short-term immunosuppressive therapy benefits IgAN patients with partial crescent formation.
  • Treatment can lead to reduced proteinuria, stabilized renal function, and improved anemia.
  • Further research is needed to understand long-term effects and optimal management strategies.
Abstract

More Related Videos

Glomerular Outgrowth as an Ex Vivo Assay to Analyze Pathways Involved in Parietal Epithelial Cell Activation06:39

Glomerular Outgrowth as an Ex Vivo Assay to Analyze Pathways Involved in Parietal Epithelial Cell Activation

Published on: August 19, 2020

5.9K
Murine Kidney Transplant Technique08:58

Murine Kidney Transplant Technique

Published on: October 20, 2015

16.8K

Related Concept Videos

Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
464
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
145
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
208
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
157
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
278
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
84